Cellectis SA (CLLS)
3.00
-0.04
(-1.31%)
USD |
NASDAQ |
May 17, 16:00
3.00
0.00 (0.00%)
Pre-Market: 20:00
Cellectis Stock Buybacks (Quarterly): -44.32M for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -44.32M |
September 30, 2023 | -0.053M |
June 30, 2023 | -0.176M |
March 31, 2023 | -23.38M |
December 31, 2022 | 0.569M |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 1.959M |
September 30, 2021 | 0.327M |
June 30, 2021 | -46.92M |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.183M |
September 30, 2020 | 1.335M |
June 30, 2020 | -1.518M |
March 31, 2020 | 0.00 |
December 31, 2019 | -0.332M |
September 30, 2019 | 0.081M |
Date | Value |
---|---|
June 30, 2019 | 0.376M |
March 31, 2019 | -0.125M |
December 31, 2018 | 7.545M |
September 30, 2018 | -1.933M |
June 30, 2018 | -230.95M |
March 31, 2018 | -3.511M |
December 31, 2017 | -0.964M |
September 30, 2017 | -39.19M |
June 30, 2017 | -0.858M |
March 31, 2017 | -0.292M |
December 31, 2016 | -0.063M |
September 30, 2016 | -0.1693M |
June 30, 2016 | -0.0128M |
March 31, 2016 | -0.3309M |
December 31, 2015 | 0.1269M |
September 30, 2015 | -1.139M |
June 30, 2015 | -219.79M |
March 31, 2015 | -0.4191M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-46.92M
Minimum
Jun 2021
1.959M
Maximum
Dec 2021
-5.888M
Average
--
Median
Mar 2020
Stock Buybacks (Quarterly) Benchmarks
DBV Technologies SA | 0.062M |
Biophytis SA | -- |
Genfit SA | -- |
Edap TMS SA | -- |
Adaptimmune Therapeutics PLC | -29.16M |